This site use cookies
This site uses cookies that help us to improve our site by providing analytics and usage information. By clicking accept or continuing to use this site you are agreeing to our cookie policy. If you do not agree, please close this notice. Learn more

Dr Sam Fazeli

Director of Research, Global Industries, Bloomberg Intelligence


Sam Fazeli is Director of Research, Global Industries at Bloomberg Intelligence, a dynamic platform for in-depth research available on the Bloomberg Professional service at BI.

Dr. Fazeli specializes in European pharmaceuticals and biotechnology.

Dr. Fazeli has over 20 years of experience conducting equity research as a pharmaceutical analyst, working at firms such as Nomura International and HSBC.

Prior to joining Bloomberg in 2010, Dr. Fazeli worked at Piper Jaffray, Ltd. as a pharmaceutical analyst and head of European research. Before transitioning to investment banking, Dr. Fazeli was a research scientist for seven years.

Dr. Fazeli has been ranked a top analyst by both the U.K. and Pan-European Extel surveys. He received a bachelor’s of science from Cardiff University, and a Ph.D. in pharmacology from the University of London.